The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Driving efficiency in oncology care: Tactical solutions for inpatient flow challenges.
 
Catherine Delanoix
Employment - MD Anderson Cancer Center
 
Kaycee Wilson
No Relationships to Disclose
 
Corey Russell
No Relationships to Disclose
 
Amin Alousi
Honoraria - Incyte; Sanofi; Takeda
Consulting or Advisory Role - Incyte; Sanofi
 
Mayoora Muthu
No Relationships to Disclose
 
Delmy Vesho
No Relationships to Disclose
 
William Wierda
Employment - MD Anderson Cancer Center
Research Funding - Abbvie; AstraZeneca; BeOne; Bristol-Myers Squibb/Celgene/Juno; Genentech; Kite, a Gilead company; Lilly; MDACC Cancer Center Support Grant; NIH/NCI award number CA016672; Nurix; Oncternal Therapeutics, Inc
Travel, Accommodations, Expenses - Abbvie; Apellis Pharmaceuticals; AstraZeneca; Genentech/Roche; Lilly
(OPTIONAL) Uncompensated Relationships - NCCN CLL/HCL Panel Chair
 
Morgan Bruno
No Relationships to Disclose
 
Jenise Rice
No Relationships to Disclose
 
Necole Oscar
No Relationships to Disclose
 
Sascha Seurattan-Smith
No Relationships to Disclose
 
Altrivice Revis
No Relationships to Disclose
 
Emily Lessner
No Relationships to Disclose
 
Rosanna Morris
Employment - MD Anderson Cancer Center; MD Anderson Cancer Center (I)
Leadership - MD Anderson Cancer Center
 
Cecilia Aguerre
No Relationships to Disclose
 
Kim Slusser
No Relationships to Disclose
 
Jose Rivera
No Relationships to Disclose
 
Christopher Flowers
Stock and Other Ownership Interests - Foresight Diagnostics; N Power
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Curio Science; Denovo Biopharma; Epizyme; Foresight Diagnostics; Genentech/Roche; Genmab; Gilead Sciences; MorphoSys; Pharmacyclics/Janssen
Research Funding - 4D Pharma (Inst); Abbvie (Inst); Acerta Pharma (Inst); Adaptimmune (Inst); Alimera Sciences (Inst); Amgen (Inst); Bayer (Inst); Celgene (Inst); Cellectis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Iovance Biotherapeutics (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Millennium (Inst); MorphoSys (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Sanofi (Inst); Takeda (Inst); TG Therapeutics (Inst); Xencor (Inst); ZIOPHARM Oncology (Inst)
 
Marina George
Consulting or Advisory Role - Marvin Health (I)